Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $169.00 at Needham & Company LLC
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective hoisted by equities researchers at Needham & Company LLC from $154.00 to $169.00 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s target price would suggest a potential upside of […]
31 Dec 14:15 · The Markets Daily